Altre lingue Sinopharm Group Co. Ltd.

Azioni

1099

CNE100000FN7

Mercato chiuso - Hong Kong S.E. Altri mercati azionari 10:08:42 28/06/2024			Variaz. 5gg	Var. 1 gen.
20,75 ^HKD	+0,97%		-6,32%	+1,47%

10/06	Il Gruppo Sinopharm ritira la risoluzione di nominare PwC come revisore contabile	MT
06/06	BPH Global si rifornirà di prodotti a nido d'uccello dalla cinese Sinopharm; le azioni crollano del 40%.	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Sinopharm Group Co. Ltd. Declares Final Dividend for the Fiscal Year Ended December 31, 2023, Payable on 13 August 2024	13/06
Sinopharm Group Withdraws Resolution to Appoint PwC as Auditors	10/06
BPH Global to Source Bird's Nest Products from China's Sinopharm; Shares Plummet 40%	06/06
China Grants Registration Approval for Shanghai Shyndec Pharmaceutical Unit's Flu Injection	15/05
China Traditional Chinese Medicine, Sinopharm Update on Privatization Process Status	14/05
Wall Street Cues, Property Outlooks Lift Asian Stock Markets	29/04
China, Hong Kong stocks rise, led by property shares	29/04
Sinopharm Group Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Sinopharm Group Shares Fall as Higher Costs Cut Into Quarterly Profit	29/04
Sinopharm Group's Q1 Profit Falls as Operating Costs Rise	29/04
Central Bank, Tech Outlooks Lift Major Asian Stock Markets	26/04
Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets	16/04
Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials	10/04
China Production Bases of Shyndec Pharmaceutical's Unit Gets Compliance Certification from Australian Regulator	27/03
Sinopharm's Attributable Profit Jumps in 2023 on Higher Revenue	25/03
Sinopharm Group Co. Ltd. Proposes Final Dividend of for the Financial Year Ended 31 December 2023, Payable on 13 August 2024	24/03
Sinopharm Group Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24/03
China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	21/03
Sinopharm's 2023 Profit Climbs 9%; Shares Up 6%	21/03
US Inflation, Light News Flow Churns Asian Stock Markets	13/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Sinopharm Group Co. Ltd.

Azioni

1099

CNE100000FN7

Altre lingue

Filtri